Proteon Therapeutics' IPO

Proteon Therapeutics raised a round of funding on October 22, 2014. Investors include Public.

Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a human recombinant protein that aims to permanently dilate segments of blood vessels, blocks vasospasm, and reduce the formatio…

Articles about Proteon Therapeutics' IPO: